Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma Metastatic in the Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002754
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer
Duke University 6
Testing effectiveness (Phase 2)Study completedNCT00039572
What this trial is testing

Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain

Who this might be right for
Brain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer
Beth Israel Deaconess Medical Center
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT05588453
What this trial is testing

Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more
Kari Kendra 24
Early research (Phase 1)Study completedNCT02716948
What this trial is testing

SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the SpineStage IV Skin Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Large-scale testing (Phase 3)Active Not RecruitingNCT01592968
What this trial is testing

Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases

Who this might be right for
Metastatic Malignant NeoplasmMetastatic Malignant Neoplasm in the Brain
M.D. Anderson Cancer Center 88
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT03898908
What this trial is testing

Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain

Who this might be right for
Metastatic MelanomaBrain Metastases
Grupo Español Multidisciplinar de Melanoma 48
Testing effectiveness (Phase 2)Temporarily pausedNCT05669352
What this trial is testing

Oral IRAK-4 Inhibitor CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery in Patients With Melanoma Brain Metastases

Who this might be right for
Melanoma Metastatic in the Brain
University of Florida 29
Testing effectiveness (Phase 2)Looking for participantsNCT04511013
What this trial is testing

Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Who this might be right for
Acral Lentiginous MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+4 more
SWOG Cancer Research Network 112
Early research (Phase 1)Ended earlyNCT05388877
What this trial is testing

E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the Central Nervous System+1 more
Mayo Clinic 13
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Early research (Phase 1)Ended earlyNCT05341349
What this trial is testing

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Melanoma of Unknown PrimaryMetastatic Malignant Neoplasm in the Brain+4 more
Emory University 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03175432
What this trial is testing

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

Who this might be right for
BRAF V600 Wild TypeClinical Stage IV Cutaneous Melanoma AJCC v8Intracranial Melanoma+4 more
M.D. Anderson Cancer Center 29
Post-approval studies (Phase 4)Study completedNCT01794793
What this trial is testing

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Who this might be right for
Cushing's DiseaseAcromegalyNeuroendocrine Tumors+6 more
RECORDATI GROUP 337
Early research (Phase 1)Active Not RecruitingNCT05640193
What this trial is testing

LN-144 in People With Metastatic Melanoma to the Brain

Who this might be right for
Metastatic Melanoma
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT02978404
What this trial is testing

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Who this might be right for
Clear-Cell Metastatic Renal Cell CarcinomaNon Small Cell Lung Cancer MetastaticBrain Metastases, Adult+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT02910700
What this trial is testing

Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaStage III Cutaneous Melanoma AJCC v7+5 more
M.D. Anderson Cancer Center 52
Large-scale testing (Phase 3)Ended earlyNCT00020839
What this trial is testing

Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain

Who this might be right for
Melanoma (Skin)Metastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 23
Testing effectiveness (Phase 2)Study completedNCT01048554
What this trial is testing

Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System

Who this might be right for
Melanoma
Mt. Sinai Medical Center, Miami 34
Next Page